Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.